Opinions expressed by Forbes Contributors are their own. Joshua Cohen is a Boston-based writer who covers health policy. In a unique challenge to drug makers, the Dutch Pharmaceutical ...
Yesterday, Amgen announced that it would launch the U.S.’s first marketed Humira-referenced biosimilar ... price – will then pay more out-of-pocket. In the case of Amjevita, the two-price ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback